Functional Retroviral Vector for Gene Therapy of Xeroderma Pigmentosum Group D Patients
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Xeroderma pigmentosum (XP) is an autosomal recessive genetic disorder characterized by an increased frequency of skin cancer following minimal sunlight exposure. Cells isolated from XP patients are also hypersensitive to UV rays and UV-like chemicals. This sensitivity is directly related to a defect in the early steps of nucleotide excision repair (NER) of damaged DNA. No efficient treatment is available for this disease and skin cancer prevention can only be achieved by strict avoidance of sunlight exposure. Thus, we are developing a model for gene therapy in XP, particularly for patients belonging to group D. We report here the construction of a retroviral vector (LXPDSN) containing the XPD (ERCC2) cDNA, which fully complements the DNA repair deficiency of primary skin fibroblasts. Efficient integration, mRNA synthesis, and protein expression of the XPD gene were obtained in all LXPDSN-transduced XP-D fibroblasts tested. Full correction of the DNA repair defect was observed with all DNA repair assays used, such as an increased survival after UV-radiation of the transduced cells, a normal level of DNA repair synthesis (UDS), and the reactivation of a UV-irradiated reporter vector. This retroviral vector will be used to modify keratinocytes genetically to produce repair proficient reconstituted skin for engraftment to XP patients. The first step toward gene therapy for the DNA repair disease xeroderma pigmentosum (XP) has been established by Carreau et al. They report the construction of a retroviral vector containing one of the DNA repair genes, the XP complementation group D previously known as ERCC2. Gene transfer was carried out on fibroblasts from two XP complementation group D patients referred to their laboratory. Complete phenotypic correction of the DNA repair defect in cells from both patients was achieved after the introduction of a functional copy of the XPD gene. This vector will then be used to modify keratinocytes to produce repair proficient reconstituted skin for engraftment at the most exposed areas. In this view, this study represents the first step toward long-term skin cancer therapy for XP patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Defective repair replication of DNA in xeroderma pigmentosum
CLEAVER, J. E. (1968) · Nature · doi:10.1038/218652a0 · Cited by 1,729
Lehman, A. R., Kirk-Bell, S., Arlett, C. F., Paterson, M. C., Lohman, P. H., de Weerd-Kastelein, E. A., & Bootsma, D. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.1.219 · Cited by 614
The Reconstitution of Living Skin
Bell, E., Sher, S., Hull, B., Merrill, C., Rosen, S., Chamson, A., Asselineau, D., Dubertret, L., Lapiere, C., Neveux, Y., et al. (1983) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12539993 · Cited by 504
Cited by
Trichothiodystrophy: Update on the sulfur-deficient brittle hair syndromes
Itin, P. H., Sarasin, A., & Pittelkow, M. R. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.114294 · Cited by 295
Self-citationSelective Regulation of Vitamin D Receptor-Responsive Genes by TFIIH
Drané, P., Compe, E., Catez, P., Chymkowitch, P., & Egly, J.-M. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.10.007 · Cited by 75
Preclinical Corrective Gene Transfer in Xeroderma Pigmentosum Human Skin Stem Cells
Warrick, E., Garcia, M., Chagnoleau, C., Chevallier, O., Bergoglio, V., Sartori, D., Mavilio, F., Angulo, J. F., Avril, M.-F., Sarasin, A., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2011.233 · Cited by 58
Self-citation
Metadata
- Authors
- Carreau, M., Quilliet, X., Eveno, E., Salvetti, A., Danos, O., Heard, J.-M., Mezzina, M., & Sarasin, A.
- Venue
- Human Gene Therapy
- Publisher
- SAGE Publications
- Published
- 1995-10
- Volume
- 6
- Issue
- 10
- Pages
- 1307-1315
- ISSN
- 1043-0342 (ISSN-L)
- 1557-7422
- OpenAlex
- W2074476083
- Cited by
- 57
- References
- 3
- FWCI
- 1.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Functional Retroviral Vector for Gene Therapy of Xeroderma Pigmentosum Group D Patients. https://app.cochat.ai/papers/10.1089/hum.1995.6.10-1307
- The paper
- Carreau, M., Quilliet, X., Eveno, E., Salvetti, A., Danos, O., Heard, J.-M., Mezzina, M., & Sarasin, A. (1995). Functional Retroviral Vector for Gene Therapy of Xeroderma Pigmentosum Group D Patients. Human Gene Therapy. https://doi.org/10.1089/hum.1995.6.10-1307
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.